{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Temecula",
      "address_1": "26531 Ynez Rd",
      "reason_for_recall": "Abbott Vascular is initiating a recall of the Absorb Bioresorbable Vascular Scaffold (BVS) System due to studies showing elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.",
      "address_2": "",
      "product_quantity": "590 units",
      "code_info": "Australia:  Part No.         Description  1012462-08 2.5 x 08 mm Absorb BVS  1012462-12 2.5 x 12 mm Absorb BVS  1012462-18 2.5 x 18 mm Absorb BVS  1012462-23 2.5 x 23 mm Absorb BVS  1012462-28 2.5 x 28 mm Absorb BVS  1012463-08 3.0 x 08 mm Absorb BVS  1012463-12 3.0 x 12 mm Absorb BVS  1012463-18 3.0 x 18 mm Absorb BVS  1012463-23 3.0 x 23 mm Absorb BVS  1012463-28 3.0 x 28 mm Absorb BVS  1012464-12 3.5 x 12 mm Absorb BVS  1012464-18 3.5 x 18 mm Absorb BVS  1012464-23 3.5 x 23 mm Absorb BVS  1012464-28 3.5 x 28 mm Absorb BVS",
      "center_classification_date": "20170601",
      "distribution_pattern": "Australia",
      "state": "CA",
      "product_description": "Absorb Bioresorbable Vascular Scaffold (BVS) system (Australia).  The Absorb BVS is a temporary scaffold indicated for improving coronary luminal diameter that will eventually resorb and potentially facilitate normalization of vessel function in patients with ischemic heart disease due to de novo native coronary artery lesions. The treated lesion length should be less than the nominal scaffolding length (8 mm, 12 mm, 18 mm, 23 mm, 28 mm) with reference vessel diameters e 2.0 mm and d 3.8 mm.",
      "report_date": "20170607",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Abbott Vascular",
      "recall_number": "Z-2151-2017",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "77131",
      "termination_date": "20171116",
      "more_code_info": "",
      "recall_initiation_date": "20170426",
      "postal_code": "92591-4630",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}